Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study

Triple Negative Breast Cancer (TNBC) is an aggressive neoplasia with median Overall Survival (OS) less than two years. Despite the availability of new drugs, the chance of survival of these patients did not increase. The combination of low doses of drugs in a metronomic schedule showed efficacy in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerrito, Maria Grazia, De Giorgi, Marco, Pelizzoni, Davide, Bonomo, Sara Maria, Digiacomo, Nunzio, Scagliotti, Arianna, Bugarin, Cristina, Gaipa, Giuseppe, Grassilli, Emanuela, Lavitrano, Marialuisa, Giovannoni, Roberto, Bidoli, Paolo, Cazzaniga, Marina Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007943/
https://www.ncbi.nlm.nih.gov/pubmed/29937997
http://dx.doi.org/10.18632/oncotarget.25422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007943/
https://www.ncbi.nlm.nih.gov/pubmed/29937997
http://dx.doi.org/10.18632/oncotarget.25422

Ejemplares similares